We are live on
!
Find out more
SC
SMA Capital Portfolio holdings
AUM
$238M
This Fund
S&P 500
This Quarter
Est. Return
+9.29%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$232M
AUM Growth
+$22.6M
(+11%)
Cap. Flow
+$17.1M
Cap. Flow
% of AUM
7.38%
Top 10 Holdings %
Top 10 Hldgs %
43.08%
Holding
116
New
73
Increased
11
Reduced
11
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eaton
ETN
|
+$10M |
| 2 |
Caterpillar
CAT
|
+$9.26M |
| 3 |
Lockheed Martin
LMT
|
+$7.28M |
| 4 |
Air Products & Chemicals
APD
|
+$7.03M |
| 5 |
IDEX
IEX
|
+$6.78M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WCN
Waste Connections
WCN
|
+$6.49M |
| 2 |
Lincoln Electric
LECO
|
+$6.23M |
| 3 |
Carrier Global
CARR
|
+$5.81M |
| 4 |
Avery Dennison
AVY
|
+$5.46M |
| 5 |
L3Harris
LHX
|
+$5.28M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 78.8% |
| 2 | Materials | 10.31% |
| 3 | Technology | 3.93% |
| 4 | Consumer Discretionary | 3.2% |
| 5 | Consumer Staples | 1.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Travere Therapeutics
TVTX
$6.27B
| $6.09K | ﹤0.01% |
+205
| New | +$6.13K |
|
|
FOLD
77
DELISTED
Amicus Therapeutics
FOLD
| $6.09K | ﹤0.01% |
+421
| New | +$6.04K |
|
|
ACLX
78
DELISTED
Arcellx
ACLX
| $6.08K | ﹤0.01% |
+53
| New | +$4.68K |
|
79
Axsome Therapeutics
AXSM
$10.9B
| $6.08K | ﹤0.01% |
+36
| New | +$6.22K |
|
80
Cogent Biosciences
COGT
$6.39B
| $6.04K | ﹤0.01% |
+157
| New | +$5.8K |
|
81
Charles River Laboratories
CRL
$14.2B
| $5.87K | ﹤0.01% |
+34
| New | +$6.3K |
|
82
Repligen
RGEN
$10.2B
| $5.66K | ﹤0.01% |
+48
| New | +$6.71K |
|
83
Mineralys Therapeutics
MLYS
$2.29B
| $5.63K | ﹤0.01% |
+208
| New | +$6.1K |
|
84
Arcutis Biotherapeutics
ARQT
$3.19B
| $5.63K | ﹤0.01% |
+239
| New | +$6.1K |
|
85
Halozyme
HALO
$12.3B
| $5.62K | ﹤0.01% |
+87
| New | +$6.13K |
|
86
Tarsus Pharmaceuticals
TARS
$3.1B
| $5.61K | ﹤0.01% |
+80
| New | +$5.59K |
|
87
Bruker
BRKR
$8.67B
| $5.6K | ﹤0.01% |
+155
| New | +$6.48K |
|
88
Arcus Biosciences
RCUS
$3.93B
| $5.57K | ﹤0.01% |
+258
| New | +$5.57K |
|
89
Sotera Health
SHC
$5.59B
| $5.49K | ﹤0.01% |
+383
| New | +$6.36K |
|
|
SLNO
90
DELISTED
Soleno Therapeutics
SLNO
| $5.12K | ﹤0.01% |
+153
| New | +$6K |
|
91
Ocular Therapeutix
OCUL
$2.37B
| $4.85K | ﹤0.01% |
+573
| New | +$5.46K |
|
|
ALMS
92
Alumis Inc
ALMS
$3.09B
| $4.47K | ﹤0.01% |
+203
| New | +$5.08K |
|
|
MAZE
93
Maze Therapeutics
MAZE
$1.65B
| $4K | ﹤0.01% |
+134
| New | +$5.91K |
|
94
Viridian Therapeutics
VRDN
$2.76B
| $3.97K | ﹤0.01% |
+203
| New | +$6.03K |
|
95
Wave Life Sciences
WVE
$1.03B
| $3.14K | ﹤0.01% |
+433
| New | +$5.64K |
|
|
96
Avery Dennison
AVY
$13.8B
| – | – |
-30,000
| Closed | -$5.46M |
|
|
97
Carrier Global
CARR
$48.5B
| – | – |
-110,000
| Closed | -$5.81M |
|
98
Cognex
CGNX
$10.3B
| – | – |
-60,000
| Closed | -$2.16M |
|
99
CRH
CRH
$64.6B
| – | – |
-40,000
| Closed | -$4.99M |
|
100
Delta Air Lines
DAL
$55B
| – | – |
-55,000
| Closed | -$3.82M |
|
Similar funds
RMC
PFA
TCM
SAM
CWM
GRWP
CNBOF
NSB
SMA Capital's Q1 2026 Portfolio in Review
As of Q1 2026, SMA Capital held 116 positions worth $232M, up 11% from $209M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
SMA Capital deployed $17.1M of net new capital in Q1 2026, opening 73 new positions and adding to 11 existing holdings. Its largest new stake was Eaton: 28,200 shares worth $10.1M.
By sector, the portfolio is most concentrated in Industrials at 79% of assets, up from 58% a quarter earlier, followed by Materials and Technology.
On the sell side, the largest reduction was Martin Marietta Materials, an estimated $5.02M trimmed.
- SMA Capital's largest Q1 2026 buy was Eaton: 28,200 shares worth $10.1M.
- SMA Capital added most to IDEX in Q1 2026, an estimated $6.78M increase.
- SMA Capital's biggest Q1 2026 reduction was Martin Marietta Materials, cutting an estimated $5.02M.
- SMA Capital fully exited Waste Connections in Q1 2026, selling an estimated $6.49M.
- SMA Capital's ten largest holdings make up 43% of its $232M portfolio in Q1 2026.
- SMA Capital opened 73 new positions and closed 21 in Q1 2026.
- SMA Capital's portfolio value rose 11% quarter-over-quarter to $232M.
Based on SMA Capital's 13F filing for Q1 2026, filed 14 May 2026.